SELLAS Life Sciences (SLS) Liabilities from Discontinued Operations (2014 - 2017)

SELLAS Life Sciences (SLS) has 4 years of Liabilities from Discontinued Operations data on file, last reported at 6759000.0 in Q3 2017.

• Liabilities from Discontinued Operations for Q3 2017 came in at 6759000.0, up 61.12% year-over-year; the trailing twelve-month figure through Sep 2017 was 6759000.0 (up 61.12% YoY), and the FY2016 annual result was 6059000.0, up 2.26% from the prior year.
• Liabilities from Discontinued Operations declined to 6759000.0 in Q3 2017 per SLS's latest filing, from 8685000.0 in the prior quarter.
• Over five years, Liabilities from Discontinued Operations peaked at 10045000.0 in Q1 2017 and troughed at 3727000.0 in Q2 2016.
• A 4-year average of 6474800.0 and a median of 6409000.0 in 2016 frame the typical range for Liabilities from Discontinued Operations.
• The sharpest annual moves came in 2016 and 2017: Liabilities from Discontinued Operations tumbled 45.5% in 2016, then jumped 133.03% in 2017.
• A 4-year view of Liabilities from Discontinued Operations shows it stood at 7169000.0 in 2014, then retreated by 17.35% to 5925000.0 in 2015, then climbed by 2.26% to 6059000.0 in 2016, then increased by 11.55% to 6759000.0 in 2017.
• Business Quant data shows SLS's Liabilities from Discontinued Operations at 6759000.0 in Q3 2017, 8685000.0 in Q2 2017, and 10045000.0 in Q1 2017.